Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer-Reference-Cited by-同舟云学术

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

Published:2015-07-21 Issue:29 Volume:6 Page:27966-27979
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kluth Martina¹,Ahrary Ramin¹,Hube-Magg Claudia¹,Ahmed Malik¹,Volta Heinke¹,Schwemin Catina¹,Steurer Stefan¹,Wittmer Corinna¹,Wilczak Waldemar¹,Burandt Eike¹,Krech Till¹,Adam Meike²,Michl Uwe²,Heinzer Hans²,Salomon Georg²,Graefen Markus²,Koop Christina¹,Minner Sarah¹,Simon Ronald¹,Sauter Guido¹,Schlomm Thorsten²³

Affiliation:

1. Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany

2. Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Germany

3. Dept. of Urology, Section for translational prostate cancer research, University Medical Center Hamburg-Eppendorf, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ProstaMine: a bioinformatics tool for identifying subtype-specific co-alterations associated with aggressiveness in prostate cancer;Frontiers in Pharmacology;2024-05-01

2. BCL-G: 20 years of research on a non-typical protein from the BCL-2 family;Cell Death & Differentiation;2023-04-08

3. Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer;Cancer Biology and Medicine;2021

4. Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer;BMC Cancer;2020-12

5. Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence;BioMed Research International;2020-10-28